GSK Buys Flu, COVID mRNA Jab Rights From Partner CureVac
Yahoo Finance · 2 days ago
Open | 38.83 |
High | 38.91 |
Low | 37.97 |
Mkt Cap | 79.2B |
P/E (TTM) | 14.02 |
Div & Yield | 1.50 & 3.87% |
Prev. Close | 38.46 |
52 Wk. Low | 33.67 |
52 Wk. High | 45.93 |
Related stocks
(USD) | Q1 2024 | Y/Y |
---|---|---|
Revenue | 7.36B | 5.90% ▲ |
Net Income | 1.05B | 29.80% ▼ |
Diluted EPS | 1.09 | 30.40% ▼ |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q2 2024 | $0.98 | - |
Q1 2024 | $0.91 | $1.09 |
Q4 2023 | $0.76 | $0.72 |
S&P 500^GSPC | 5,567.19+30.17 (+0.54%) |
Dow 30^DJI | 39,375.87+67.87 (+0.17%) |
Nasdaq^IXIC | 18,352.76+164.46 (+0.90%) |
539.91+5.87% | |
27.23+5.34% | |
171.90+4.88% |